Lodelcizumab Antibody
Lodelcizumab (LGT 209) is a research-grade monoclonal antibody that inhibits PCSK9, a key regulator of LDL receptor degradation. It is utilized in preclinical in vitro and in vivo studies to investigate mechanisms and potential therapeutic strategies for hypercholesterolemia and associated cardiovascular diseases.
Product Specifications
Product Name Alternative
PCSK9, LGT 209, LGT209
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
5.08 mg/mL
Purity
95.50% (May vary between batches)
Molecular Weight
145.58 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog